Adenomyosis Diagnosis
Adenomyosis Diagnosis
There is no blood test for this condition, and neither scan is perfect at finding it. The diagnosis is assembled from the bleeding history, the pain history, an examination that often finds the womb enlarged and tender, and imaging read specifically for the changes in the muscle of the womb. The only certain way to confirm it is to examine the womb itself, which until recently meant examining it after removal — and no sensible plan removes a womb in order to make a diagnosis. That is why the diagnosis is usually described as clinical, and why it is entirely reasonable to begin treatment on it.
There is no blood test, and the blood count is not one
The absence of a simple test is why this condition is often carried for years without a name:
- No blood test identifies it. There is no marker that rises with the disease and falls when it is treated, which means the diagnosis rests on the clinical picture rather than on a number.
- A blood count is performed, but for a different reason. It is done to find out whether the bleeding has produced anaemia that needs treating, not to identify the cause. A normal count is common and says nothing either way about the diagnosis.
- CA-125 is not a diagnostic test. It can be raised here and it is raised by many other things, so it is not used to confirm or exclude the condition. Treating a modestly raised result as evidence of the disease, or of something worse, is a common and avoidable error.
- The two histories are the primary investigation. How the bleeding has changed across years and whether the pain has worsened in the same direction carry more diagnostic weight than any single test, and neither can be reconstructed from an image.
Why this shapes the whole pathway. A condition diagnosed from a history rather than from a test has to be treated on the history. Waiting for a result that does not exist is how the delay turns into years of managed bleeding without a plan.
What transvaginal ultrasound can and cannot show
Ultrasound is the first-line test and it does change the picture, and it is worth being precise about its limits:
- It looks for particular changes within the muscle of the womb. An uneven, mottled texture of the muscle, small cystic spaces within it, and loss of the normal definition between the inner and outer muscle layers are the features that are read for. The womb may also appear globular rather than pear-shaped and larger than expected.
- It also shows the other explanations. Fibroids, polyps, the thickness of the lining, the ovaries and free fluid are all assessed in the same examination, which is how conditions that imitate the bleeding are identified or excluded.
- A normal scan does not exclude it. Where the changes are mild, ultrasound can be reported as normal, and the muscle changes of adenomyosis are less obvious than a fibroid. A negative scan is an absence of evidence, and it is not a reason to stop investigating bleeding that has clearly changed.
Why the request matters as much as the result. A scan performed by someone looking specifically for these changes, with the possibility in mind, finds things a routine scan does not. Putting the question in the request is part of the assessment.
What MRI adds, and what the junctional zone is
MRI is not needed for everyone, and it is worth being clear about when it earns its place:
- It shows the distribution of the disease more precisely. Whether the changes are diffuse through the muscle or focal in one area is the distinction that decides whether a womb-preserving operation is even possible, and MRI is the test that separates the two.
- It measures the thickness of the junctional zone. The inner layer of muscle next to the cavity is where the muscles that control the period are concentrated. Measurement of this layer is one of the findings that supports the diagnosis, and where it is normal the diagnosis becomes less likely.
- It tells adenomyosis and fibroids apart. A focal adenomyoma and a fibroid can look similar, and they are not treated the same way: a fibroid can be shelled out from the surrounding muscle, whereas adenomyosis has no plane to separate it. Where the plan is an operation, getting this distinction right beforehand matters.
Why the distinction between diffuse and focal matters so much. It is the difference between an operation that keeps the womb and one that cannot. Establishing it before treatment rather than during it is what allows the options to be set out honestly.
What actually confirms the diagnosis
This is the part of the pathway most often misunderstood, and it is worth stating plainly:
- Examining the womb itself is the reference standard. Looking at the muscle directly, usually after the womb has been removed for another reason or as part of an operation, is the only certain way to confirm the condition.
- That standard is not worth reaching for its own sake. Removing a womb in order to confirm a diagnosis that could be managed without an operation is not a reasonable use of an operation, and taking a needle sample from the muscle is not performed as a routine diagnostic step because it is unreliable and it carries its own risk.
- So the diagnosis is made on the combination. Two histories of a consistent direction, a womb found to be enlarged and tender, and imaging read specifically for the changes of the disease: together these establish the diagnosis with enough confidence to act on.
- The diagnosis can be revised. If the bleeding does not respond as expected, if the pain changes character, or if a further examination finds something else, the assessment is repeated. A clinical diagnosis is a working conclusion rather than a verdict.
Why this is explained before treatment starts. Patients who expect a test to settle the question read the absence of one as uncertainty. Understanding that a clinical diagnosis is the normal way this condition is diagnosed is what allows treatment to begin on time.
Treating on a clinical diagnosis
This is the practical consequence of everything above, and it is deliberate:
- Treatment for the bleeding can begin on the history and the examination. Waiting for certainty that only an operation could provide means waiting indefinitely, and in the meantime anaemia accumulates and the pain has another year in which to worsen.
- Waiting has a measurable cost. The blood count falls, the pain becomes harder to control, and time passes that matters if a pregnancy is wanted. Postponing treatment is not a neutral position, it is a decision with consequences.
- What the assessment must still do is exclude. Beginning treatment on a clinical diagnosis is not the same as never looking for alternatives. Polyps, thyroid disease, a bleeding disorder and a pregnancy-related cause are assessed in parallel, not afterwards.
Why this is stated explicitly in the plan. Many patients arrive expecting to be told that nothing can be judged until a test has settled the question. Correcting that expectation is part of the consultation, because the alternative is another year of managed bleeding with no plan behind it.
What is not done, and why
A useful assessment is defined as much by what it leaves out as by what it includes:
- Repeated ultrasound to watch the disease is not useful. Imaging does not measure how active this condition is, so repeating it at intervals produces reassurance that the test cannot support, and the size of the womb is not a measure of how much the bleeding is costing.
- Serial blood markers are not part of follow-up. There is no marker to follow, and treating a non-specific result as a measure of disease activity leads to decisions based on nothing.
- Sampling the muscle to confirm the diagnosis is not done. It is unreliable, it carries a risk that a blood test does not, and it would not change what is offered, which is the test every investigation has to pass.
Why saying no is part of the plan. Someone who has bled heavily for years will accept almost any test that is offered, and a test that cannot answer the question only postpones the treatment that can. Naming what will not be done is how the assessment stays about decisions.